MedTrace Logo

Effects on Experimental Dyspnea of High Flow Nasal Cannula

NCT03469037 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2019-02-15

No results posted yet for this study

Summary

To develop an experimental model of dyspnea by external thoraco-abdominal elastic strapping at rest in order to study the mechanisms involved in the relief of dyspnea by the administration of high flow by nasal cannula (HFNC).

Conditions

Interventions

DEVICE

Optiflow with an inspired fraction of oxygen of 100%

Respiratory gaz heated and humidified system of delivery with a fraction of oxygen inspired of 100%

DEVICE

Optiflow with an inspired fraction of oxygen of 21%

Respiratory gaz heated and humidified system of delivery with a fraction of oxygen inspired of 21%

Sponsors & Collaborators

  • Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil

    lead OTHER

Principal Investigators

  • Capucine Morelot-Panzini, Doctor · Service de Pneumologie de la Pitié-Salpétrière

  • Thomas Similowski, PHD · Service de Pneumologie de la Pitié-Salpétrière

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-22
Primary Completion
2018-11-02
Completion
2018-11-02

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03469037 on ClinicalTrials.gov